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Abstract
Background: Medicinal plants play great roles in the treatment of various infectious diseases. Rhamnus prinoides is
one of the medicinal plants used traditionally for treatment of bacterial diseases. The antibacterial activity of the crude
extract of the plant had been shown by a previous study, but this study was undertaken to further the claimed medicinal
use of the plant by screening its solvent fractions for the said activity so that it could serve as a basis for subsequent
studies.
Methods: The solvent fractions of the plant were obtained by successive soxhlet extraction with solvents of increasing
polarity, with chloroform and methanol, followed by maceration of the marc of methanol fraction with water.
The antibacterial activity of the solvent fractions was evaluated on seven bacterial species using agar well diffusion
method at different concentrations (78 mg/well, 39 mg/well and 19.5 mg/well) in the presence of positive and
negative controls. The minimum inhibitory concentration of the solvent fractions was determined by micro-broth
dilution method using resazurin as indicator.
Result: Methanol and chloroform fractions revealed antibacterial activities against the growth of test bacterial strains
with varying antibacterial spectrum and the susceptible bacterial species were Staphylococcus aureus, Streptococcus
pyogen, Streptococcus pneumoniae and Salmonella typhi. The average minimum inhibitory concentration value of the
methanol and chloroform fractions ranged from 8.13 mg/ml to 32.5 mg/ml and from 8.13 mg/ml to 16.25 mg/ml,
respectively.
Conclusion: The methanol and chloroform fractions demonstrated significant antibacterial activities against the growth
of pathogenic bacteria but the aqueous fraction did not reveal antibacterial activity against any of the test bacteria.
Keywords: Antibacterial activity, Minimum inhibitory concentration, Staphylococcus aureus, Streptococcus pyogen,
Streptococcus pneumoniae, Salmonella typhi
Abbreviations: DMSO, Dimethylsulfoxide; ENT, Ear, nose and throat; S. aureus, Staphylococcus aureus; ATCC, American
type cell collection; MIC, Minimum inhibitory concentration; MBC, Minimum bactericidal concentration; MHA, Mueller
hinton agar; MHB, Mueller hinton broth; S. pyogen species, Staphylococcus pyogen
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Background
Infectious diseases are the continuous major causes of
death in the world, with a great impact in developing
countries [1, 2]. The periodically emerging new and old
infectious diseases greatly magnify the global burden of
infectious diseases [3]. The majorities of emerging infec-
tious events are caused by bacteria which can be asso-
ciated with evolution of drug resistant strains and
overwhelming of the natural host defenses [4, 5].
Therefore, the search of new or alternative mecha-
nisms to effectively treat and prevent infectious diseases,
particularly bacterial diseases, have to be encouraged to
effectively reduce these global burden. Medicinal plants
have been used for treatment of different infectious
diseases and thus accepted as alternative approaches. In
Africa, 90 % of the population relies on traditional
healers to meet their primary healthcare needs [6] which
indicate the presence of many medicinal plants with a
potential source of new drugs.
Rhamnus prinoides L’Herit (Rhamnaceae) is one of
the medicinal plants that have been used traditionally
for the treatment of different infectious diseases. Rham-
nus prinoides has different ethnomedicinal uses in dif-
ferent countries of Africa. In Kenya, traditionally, the
different parts of plant are used in the management of
Ear, Nose and Throat (ENT) infections, gonorrhea,
malaria and brucellosis [7, 8]. In Ethiopia, the leaves,
fruits or roots of Rhamnus prinoides is used to treat
tonsillitis [9–13]. In addition, the different parts of the
plant have been used in the management of scabies,
hepatitis, tinea capitis, 'chiffea' (Eczema), ringworm and
dandruff [11, 14–17]. Moreover, the leaf of the plant is
used for the management of waterborne and related
diseases [18].
The purpose of the study was to evaluate the in vitro
antibacterial activities of the crude and solvent fractions
of the leaves of Rhamnus prinoides against clinical and
standard strains of selected bacterial species, which can
in turn provide a clue for the isolation and identification
of active principle(s) responsible for the antibacterial
activity.
Methods
Collection and authentication of the plant material
The leaves of Rhamnus prinoides was collected from
the cultivated garden of a family in October 2014,
around Debre Markos Town, East Gojjam Zone, Amhara
Region, 300 km away from Addis Ababa, North West
Ethiopia and identified by a taxonomist at the National
Herbarium, Department of Biology, College of Natural
and Computational Sciences, Addis Ababa University, and




One hundred fifty gram of coarsely powdered leaves was
macerated in 80 % methanol for a period of 3 days with
occasional shaking using a shaker (Bibby scientific lim-
ited stone Staffo Reshire, United Kingdom). The extract
was filtered with Whatman No 1 filter paper (Schleicher
and Schuell Microscience Gmbh, Germany). The residue
was remacerated for the second and third times with
fresh solvent. The extracted solution was combined and
concentrated by Rota vapor (Buchi Rota-vapor R-200,
Switzerland). Then, it was dried in a lyophilizer (Operan,
Korea vacuum limited, Korea).
Solvent fractionation
The solvent fractionation was conducted by using both
Soxhlet and maceration techniques. Soxhlet extraction
was carried out by sequential extraction of the powdered
leaves in solvents of increasing polarity viz. chloroform
and methanol as described by a study [19]. The pow-
dered leaf was extracted by chloroform at a temperature
not exceeding 40 °C. This extraction process was con-
tinued exhaustively until clear solution in the timble
was siphoned into the solvent flask. Then, the chloro-
form fraction was filtered with Whatman No. 1 filter
paper and concentrated using rotary evaporator. The
concentrated solution was dried in oven at a temp-
erature of 40 °C.
The dried marc of the chloroform fraction was ex-
tracted using absolute methanol following the same pro-
cedure described for chloroform fraction. Finally, the
dried marc of methanol fraction was macerated with dis-
tilled water and dried in the lyophilizer to get the aque-
ous fraction.
The percentage yield of the crude extract, aqueous
fraction, methanol fraction, and chloroform fraction
were 17.5 %, 4.32 %, 8.74 % and 6.21 %, respectively.
Each dried crude extract and solvent fractions was
reconstituted in sterile 20 % DMSO (for crude extract
and the methanol fraction), 70 % DMSO (for the chloro-
form fraction) or sterilized distilled water (for aqueous
fraction) to prepare the tested concentrations of the
plant material.
Phytochemical screening
The qualitative phytochemical investigations of the crude
extract, and chloroform, methanol and aqueous fractions
of leaves of Rhamnus prinoides were carried out using
standard tests [20–22]
Inoculum preparation and standardization
Standard and clinical isolates of different bacterial strains
including Escherichia coli (E. coli) (American Type Cul-
ture Collection (ATCC) 25922), E. coli (clinical isolate),
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Pseudomonas aeruginosa (P. aeruginosa) (ATCC 27853),
P. aeruginosa (Clinical isolate), Staphylococcus aureus (S.
aureus) (ATCC 25923), S. aureus (clinical isolate), Shigella
flexneri (S. fleneri) (ATCC 12022), S. fleneri (clinical iso-
lates), Streptococcus pneumoniae (S.pneumoniae) (ATCC
49619), S. pneumoniae (clinical isolate), Streptococcus pyo-
gen (S. pyogen) (ATCC 19615), S.pyogen (clinical isolate)
and Salmonella typhi (S. typhi) (ATCC 13062) were ob-
tained from Ethiopian Public Health Institution (EPHI).
Then, each bacterial strain was inoculated and spread
on pre-labeled nutrient agar and 5 % sheep blood agar
(for streptococcus species) aseptically in a Safety Cabi-
net (Bioair instruments, Eurolone® Company, Italy) and
incubated for 24 h at 37 °C. The bacterial turbidity of
each bacterium was prepared by growth method and
standardized by following the guideline of Clinical and
Laboratory Standard Institute [23]. The turbidity of the
inoculum tube was adjusted visually by either adding
bacterial colonies or by adding sterile normal saline so-




The antibacterial agar well diffusion assay was conducted
by following the methods described previously [24]. The
standardized bacterial broth culture prepared in section
2.4 were streaked evenly on sterile MHA plates or MHA
with 5 % sheep blood (for streptococcus species) with cot-
ton swab. After thirty minutes, on each plate, four equidis-
tant wells were made with a 6 mm diameter sterilized
cork borer. The labeled wells were filled with 100 μl of
780 mg/ml, 390 mg/ml, and 195 mg/ml of the crude or
each of the solvent fractions making the final concentra-
tion of 78 mg/well, 39 mg/well and 19.5 mg/well respect-
ively. In addition, the commercial antibiotic discs of
ampicillin 0.01 mg/disc (for streptococcus species), cefoxi-
tin 0.03 mg/disc (for E. coli and S. aureus species) and cip-
rofloxacin 0.005 mg/disc (for other bacterial strains) were
used as a positive control. The solvents of the crude and
each fraction were used as negative controls. Then, the
plates were left undisturbed for about 2 h at room
temperature. After incubation at 37 °C for 24 h, the zone
of inhibition was measured using a ruler. The experiment
was performed in three independent tests for each bacter-
ial strains and the mean of zones of inhibition was calcu-
lated for each extract.
Determination of the Minimum Inhibitory Concentration (MIC)
The crude extract and solvent fractions that showed
antibacterial activity by agar well diffusion method were
subjected to serial resazurin based microtitre dilution
technique on 96 well plates (Greiner Bio-One, Germany)
as described by previous studies [25, 26]. The first column
of microtiter plate was filled with 100 μl stock solution
(390 mg/ml) of the crude or each active solvent fraction of
test material except the last well in which equal amount of
the respective solvent was added. Then, all the wells of mi-
crotitre plates were filled with sterilized 100 μl of MHB
[23] or BHI (for streptococcus species) [27]. Two fold
serial dilution of the crude extract or solvent fraction
(throughout the row) was carried out until the 10th col-
umn. The 11th and 12th column were used as the growth
control for labeled bacterium in which the 100 μl of the
solvents of the extract or that of the solvent fraction was
added. Then, 30 μl of 0.01 % w/v resazurin solution was
added and mixed in each well.
Briefly, within 15 min of standardization to approxi-
mately 5 × 106 CFU/mL with the respective broth, 20 μl
of bacterial suspension was added to each well except
7th and 8th row which were reserved as extract color
contrast control and sterility control, respectively. Sub-
sequently, the serial dilution procedures gave rise to a
final concentration of the plant material ranging from
130 mg/ml to 0.26 mg/ml.
Finally, after wrapping each plate loosely with parafilm,
the plates were incubated at 37 °C for 24 h. In the ex-
periment, each plate had a set of three controls: (a) a
column with all solutions with the exception of the test
extract or fraction, (b) a row with all solutions except
bacterial suspension and the extract or fraction was used
as sterility control, (c) a row with all solutions except the
bacterial inoculums was used as color contrast control.
After incubation, any color change observed from pur-
ple to pink or colorless was taken as positive for growth
of bacteria. The lowest concentration of plant leaf ex-
tract at which no color change occurred was recorded as
the MIC value. All the experiments were performed in
triplicates for each bacterium. The average value was
taken for the MIC of test plant material.
Determination of Minimum Bactericidal Concentration (MBC)
MBC was determined by a method described in different
studies [26]. In this technique, the contents of all wells
containing a concentration of test material above the
MIC value from each triplicate, in the MIC determin-
ation test, was streaked on MHA or MHA supplemented
with 5 % sheep blood (for streptococcus species) with
wire loop aseptically and incubated at 37 °C for 24 h.
The lowest concentration of the extract which showed
no bacterial growth after incubation was observed for
each triplicate and noted as the MBC. The average value
was taken for the MBC of test material against each
bacterium.
Statistical analysis
The experimental data are expressed as mean ± Standard
Error of the Mean (SEM). Data are analyzed using the
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Statistical Package for the Social Sciences (SPSS), version
16.0 software. The statistical differences of the mean
zone of inhibition of crude extract and solvent fractions
for individual bacterium was carried out by employing
one way analysis of variance (ANOVA) followed by
Tukey Post Hoc Multiple Comparison test at a signifi-
cance level of P < 0.05.
Results
Antibacterial activity
The growth of test bacterial strains was inhibited by the
tested concentrations of the crude extract, the metha-
nol fraction and chloroform fraction of the leaves of
Rhamnus prinoides in concentration dependent manner
(Tables 1, 2 and 3). However, the aqueous fraction was
devoid of an antibacterial activity against any of the test
bacterium. Among the test bacteria, the most suscep-
tible bacterium at 78 mg/well of crude extract was
standard strains of S. aureus followed by clinical iso-
lates of S. aureus and standard strains of S. pyogen with
a mean zone of inhibition of 22 mm, 21.67 mm and
20.33 mm, respectively. In addition, among the gram
negative bacteria, standard strains of S. typhi were most
susceptible at 78 mg/well of the crude extract with the
maximum mean zone of inhibition of 17.67 mm
(Table 1).
Similar to the crude extract, the most susceptible bacter-
ium against methanol fraction was standard strains of S.
aureus followed by standard strains of S. pneumoniae with
a mean zone of inhibition of 16.17 mm and 16 mm,
respectively, at 78 mg/well concentration. The zone of
inhibition of methanol fraction at 78 mg/well against S.
typhi was also greater than that of its activity against the
other gram negative test bacterial strains (Tables 2 and 3).
The most sensitive bacterium against chloroform frac-
tion at 78 mg/well concentration was standard strains of
S. pneumoniae followed by standard strains of S. pyogen
with a mean zone of inhibition of 15.67 mm, and 15 mm
(Tables 1, 2 and 3). However, this fraction produced no
antibacterial activity coverage against P. aeruginosa and E.
coli regardless of their respective strains. Generally, the
antibacterial activities of the chloroform fraction in terms
of its zone of inhibition were slightly lower than that of
the methanol fraction against each bacterial strain for
which it was active, especially at 78 mg/well and 39 mg/
well concentrations even though the difference at the cor-
responding concentration were not statistically significant.
Minimum inhibitory concentration of crude extract and
solvent fractions
As presented in Table 4, for the crude extract, the max-
imum MIC obtained was 8.13 mg/ml (against E. coli, P.
aeruginosa and S. pneumoniae species) and the minimum
Table 1 Zone of inhibition (in mm) of the different concentrations of crude extract and solvent fractions of the leaves of Rhamnus
prinoides against gram positive bacteria
Category of test Concentration Bacteria
S. aureus S. pyogen S. pneumoniae
Stand Clinic Stand Clinic Stand Clinic
Crude 19.5 mg/well 16.67 ± 0.88a3d2 16.67 ± 0.33a3c1d3 13.67 ± 0.88a3c2d3 12.33 ± 0.33a3c1d2 13.33 ± 0.33a3d2 11.67 ± 0.33a3c2d3
39 mg/well 19.67 ± 0.88a3 19.00 ± 0.58a3d1 18.33 ± 0.67a3 16.33 ± 0.67a3 16.00 ± 1.00a2 15.33 ± 0.33a3d2
78 mg/well 22.00 ± 0.58a2 21.67 ± 0.33a2 20.33 ± 0.33a3 18.67 ± 0.33a3 19.33 ± 1.20a1 18.00 ± 0.00a3
Cef 0.03 mg/disc* 28.33 ± 0.58 26.33 ± 0.67 NT NT NT NT
Amp 0.01 mg/disc* NT NT 27.33 ± 0.67 26.33 ± 1.20 24.00 ± 0.58 23.00 ± 0.58
Methanol 19.5 mg/well 13.00 ± 0.58a3d2e2 11.67 ± 0.33 a3d2e3 12.67 ± 0.33a3d1 11.67 ± 0.33a3d2 12.33 ± 0.88a3d1 11.33 ± 0.33a3d3
39 mg/well 14.33 ± 0.33a3f3 13.33 ± 0.33a3f3 14.00 ± 0.58a3f2 12.67 ± 0.33a3d1f3 14.33 ± 0.33a3 13.67 ± 0.33a3d1
78 mg/well 16.17 ± 0.44a3g3 15.33 ± 0.67a3g3 15.00 ± 0.58a3g3 15.00 ± 0.58a3g3 16.00 ± 0.58a3 15.33 ± 0.33a3g2
Cef 0.03 mg/disc* 27.67 ± 0.33 26.33 ± 0 .33 NT NT NT NT
Amp 0.01 mg/disc* NT NT 28.00 ± 0.00 26.33 ± 0 .67 25.00 ± 0 .58 23.67 ± 0.33
Chloroform 19.5 mg/well 11.67 ± 0.33a3d1e3 11.67 ± 0.33a3d1e3 12.00 ± 0.58 a3d2 10.67 ± 0.33a3d2 12.00 ± 0.58a3d2 11.00 ± 0.00a3d2
39 mg/well 13.00 ± 0.58a3f3 13.33 ± 0.33a3f3 13.67 ± 0.33 a3f3 12.00 ± 0.58 a3f3 14.00 ± 0.58a3 13.00 ± 0.58a3f2
78 mg/well 14.33 ± 0.33a3g3 14.00 ± 0.58a3g3 15.00 ± 0.58 a3g3 13.67 ± 0.58a3g3 15.67 ± 0.33a3g1 15.00 ± 0.58a3g3
Cef 0.03 mg/disc* 27.00 ± 0.57 26.33 ± 0.33 NT NT NT NT
Amp 0.01 mg/disc* NT NT 27.67 ± 0.33 27.00 ± 0.58 25.00 ± 0.58 23.67 ± 0.33
Values are expressed as Mean ± S.E.M (n = 3), analysis was performed with One-Way ANOVA followed by Tukey test; acompared to positive control, bto 19.5 mg/well,
cto 39 mg/well, dto 78 mg/well, eto crude 19.5 mg/well, fto crude 39 mg/well, gto crude 78 mg/well; 1P < 0.05, 2P < 0.01, 3P < 0.001. The negative control has shown
no antibacterial activity. * = positive controls, Stand = standard (ATCC) strains, Clinic. = clinically isolated strains, NT = not tested, Cef = Cefoxitin,
Amp = ampicillin, Cip = Ciprofloxacin
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MIC was 2.03 mg/ml (against staphylococcus species).
Moreover, unlike the slight differences between the figures
of zone of inhibition of the clinically isolated and standard
strains within the same species, the MIC values were equal
for the strains of the same species with the exception of S.
flexneri for which the MIC of the clinical isolate is slightly
higher (5.42 mg/ml) than that of its standard ones
(4.06 mg/ml).
The MIC value for methanol fraction ranged from
32.5 mg/ml (against E. coli species) to 8.13 mg/ml (against
Table 2 Zone of inhibition (in mm) of the different concentrations of crude and solvent fractions of the leaves of Rhamnus prinoides
against gram negative bacteria
Category of test Concentration Bacteria
S. flexneri E. coli
Stand Clinic Stand clinic
Crude 19.5 mg/well 12.00 ± 0.58a3d2 11.67 ± 0.33 a3d2 11.67 ± .88a3d1 11.33 ± 0.67a3d2
39 mg/well 14.00 ± 0.00a3d1 13.67 ± 0.33 a3d1 12.67 ± 0.33a3 12.67 ± 0.33a3
78 mg/well 17.00 ± 0.58a3 16.00 ± 0.58 a3 15.00 ± 0.00a3 14.50 ± 0.29 a3
Cef 0.03 mg/disc* NT NT 28.33 ± 0.88 27.00 ± 0.58
Cip 0.005 mg/disc* 26.33 ± 0.67 25.00 ± 0.58 NT NT
Methanol 19.5 mg/well 11.00 ± 0.00a3d2 10.67 ± 0.67a3d2 10.33 ± 0.33a3d3 9.00 ± 0.58a3c2d3
39 mg/well 13.00 ± 0.58a3 12.67 ± 0.33a3 12.00 ± 0.58a3d1 11.67 ± 0.33a3d2
78 mg/well 15.00 ± 0.58a3 14.67 ± 0.33a3 14.50 ± 0.29a3 14.33 ± 0.33a3
Cef 0.03 mg/disc* NT NT 27.67 ± 0.33 26.67 ± 0.33
Cip 0.005 mg/disc* 27.00 ± 0.58 26.33 ± 0.67 NT NT
Chloroform 19.5 mg/well 10.00 ± 0.58a3d2 10.33 ± 0.33a3 — —
39 mg/well 11.33 ± 0.33a3f1 11.67 ± 0.67a3 —— —
78 mg/well 13.33 ± 0.33 a3g2 12.33 ± 0.33a3g2 — —
Cip 0.005 mg/disc* 25.00 ± 0.58 24.67 ± 0.33 NT NT
Values are expressed as Mean ± S.E.M (n = 3), analysis was performed with One-Way ANOVA followed by Tukey test acompared positive control, bto 19.5 mg/well,
cto 39 mg/well, dto 78 mg/well, eto crude 19.5 mg/well, fto crude 39 mg/well, gto crude 78 mg/well; 1P < 0.05, 2P < 0.01, 3P < 0.001. The negative control has shown
no antibacterial activity. * = positive controls, Stand = standard (ATCC) strains whereas Clinic. = clinically isolated strains, NT = not tested, Cef = Cefoxitin,
Cip = Ciprofloxacin, — = no activitiy
Table 3 Zone of inhibition (in mm) of the different concentrations of crude and solvent fractions of the leaves of Rhamnus prinoides
against gram negative bacteria
Category of test Concentration Bacteria
P. aeruginosa S. typhi
Stand Clinic stand
Crude 19.5 mg/well 11.00 ± 0.58a3c1d2 10.67 ± 0.88a3 13.33 ± 0.33a3d2
39 mg/well 13.33 ± 0.33a3 13.00 ± 0.58a3 14.00 ± 0.58a3d2
78 mg/well 14.33 ± 0.33 a3 14.00 ± 0.58a3 17.67 ± 0.67a3
Cip 0.005 mg/disc* 25.67 ± 0.33 24.33 ± 0.88 30.00 ± 0.58
Methanol 19.5 mg/well 10.33 ± 0.33a3d1 10.33 ± 0.33a3c1d2 11.00 ± 0.58a3d2
39 mg/well 12.00 ± 1.00a3 12.33 ± 0.33a3 12.67 ± 0.88a3d1
78 mg/well 13.67 ± 0.33a3 13.67 ± 0.33a3 15.67 ± 0.33a3
Cip 0.005 mg/disc* 24.33 ± 0.33 24.00 ± 0.58 31.00 ± 0.58
Chloroform 19.5 mg/well — — 10.33 ± 0.33a3d2e1
39 mg/well — — 11.67 ± 0.33a3
78 mg/well — — 13.00 ± 0.58a3g3
Cip 0.005 mg/disc* NT NT 30.33 ± 0.33
Values are expressed as Mean ± S.E.M (n = 3), analysis was performed with One-Way ANOVA followed by Tukey test; acompared to positive control, bto 19.5 mg/well,
cto 39 mg/well, dto 78 mg/well, eto crude 19.5 mg/well, fto crude 39 mg/well, gto crude 78 mg/well; 1P < 0.05, 2P < 0.01, 3P < 0.001. The negative control has shown no
antibacterial activity * = positive control, Stand = standard (ATCC) strains whereas Clinic = clinically isolated strains, Cip = Ciprofloxacin,— = no activity
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S. aureus and S. pyogen species). The MIC figures of the
chloroform fraction ranged from 8.13 mg/ml to 16.25 mg/
ml in all bacterial species for which it was active. For the
same bacterial species tested, the MIC of the two active
solvent fractions were equal with the exception of clinic-
ally isolated strains of S. aureus and S. pyogen for which
the methanol fraction was more potent than the chloro-
form fraction.
Minimum bactericidal concentration of crude extract and
solvent fractions
The MBC of the crude extract of the study plant was in
the range of 16.25 mg/ml (against both strains of S.
pneumoniae) to 2.03 mg/ml (against standard strains of
Staphylococcus species). The corresponding values of
the methanol fraction were 65 mg/ml (against clinical
isolate of E. coli) and 13.54 mg/ml (against standard
strain of S. pyogen). The MBC values of the chloroform
fraction ranged from 32.5 mg/ml to 16.25 mg/ml against
the growth of the susceptible bacterial species (Table 5).
Taken together, the crude extract was more potent and
killed the bacteria at lower concentration compared to
that of the methanol and chloroform fractions.
Phytochemical constituents of the crude extract and
solvent fractions
According to the qualitative phytochemical screening
study, the crude extract of the leaf of Rhamnus prinoides
was found to be positive for the presence of all of the
tested secondary metabolites except for cardiac glyco-
sides, whereas the methanol fraction was positive for the
presence of alkaloids, tannins, flavonoids, saponins, poly-
phenols and terpenoids. The chloroform fraction was
confirmed for the presence of tannins, polyphenols, ter-
penoids, anthraquinones and flavonoids while the aque-
ous fraction contained only saponins (Table 6).
Discussion
The present study was undertaken to determine on which
fractions do the constituents of the leaves of Rhamnus pri-
noides responsible for its antibacterial activity are concen-
trated. In addition, even though the antibacterial activity
of the crude extract of the plant had been studied by a
previous work in Gondar, Ethiopia [28], the crude extract
was also evaluated in this study to assure its antibacterial
activity as there was differences in geographical areas of
plant collection, bacterial stains, solvent system and the
parts of the plant used for extraction purpose.
According to the present study, the zones of inhibition
of the bioactive fractions were lower than that of the
crude extract at equal concentrations against the individ-
ual strains of test bacteria. The reason for the enhanced
antibacterial activity of the crude extract might be due
to the synergistic or additive effect of the secondary me-
tabolites that were relatively partitioned in the solvent
fractions as it had been extracted by the successive sol-
vents of increasing polarity.
The crude extract and the methanol fraction had simi-
lar antibacterial activity profile in terms of antibacterial
activity coverage and their activity was higher in the
gram positive bacteria than that of the majority of gram
negative test bacteria at their comparable concentration.
Table 4 The MIC (in mg/ml) of the crude extract and the solvent fractions of the leaves of Rhamnus prinoides against gram positive
and gram negative bacteria
Bacteria Crude extract Solvent fractions
Methanol fraction Chloroform fraction
MIC MIC MIC
S. aureus Stand. 2.03 ± 0.00 8.13 ± 0.00 8.13 ± 0.00
Clinc. 2.03 ± 0.00 8.13 ± 0.00 16.25 ± 0.00
S. pyogen Stand. 4.06 ± 0.00 8.13 ± 0.00 8.13 ± 0.00
Clinc. 4.06 ± 0.00 8.13 ± 0.00 16.25 ± 0.00
S. pneumoniae Stand. 8.13 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
Clinc. 8.13 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
S. flexneri Stand. 4.06 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
Clinc. 5.42 ± 1.36 16.25 ± 0.00 16.25 ± 0.00
E. coli Stand. 8.13 ± 0.00 32.50 ± 0.00 —
Clinc. 8.13 ± 0.00 32.50 ± 0.00 —
P. aeruginosa Stand. 8.13 ± 0.00 16.25 ± 0.00 —
Clinic 8.13 ± 0.00 16.25 ± 0.00 —
S. typhi Stand 4.06 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
MIC =Minimum Inhibitory Concentration, the values are the average of triplicate tests. Stand. = standard (ATCC) strains whereas Clinic. = clinically isolated strains
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Similarly, the mean zone of inhibition of chloroform frac-
tion at its comparable concentration against gram positive
bacteria was also greater than that of gram negative bac-
teria. Obviously, it is not surprising that gram negative
bacteria were less susceptible for the crude and the active
solvent fractions of the study plant as they have an outer
membrane which precludes the partial penetration of the
bioactive phytochemicals unlike that of the gram positive
bacteria having less effective permeability barrier [29, 30].
Unlike methanol fraction, the chloroform fraction was
not active against the clinical and standard strains of P.
aeruginosa and E. coli. In addition, these species were
the least susceptible bacteria for the methanol fraction
and crude extract at equal concentrations compared to
the other test bacteria. The possible reason for the less
susceptible nature of these bacterial species could be due
to the differences in the resistance mechanisms to the bio-
active compounds detected in each solvent fraction
among the test bacteria. For example, P. aeruginosa and E.
cloi have the inherent ability of producing different resist-
ance mechanisms like efflux pump [31], expressing AmpC
β-lactamase [32] or biofilm formation [33] which could
hinder the antibacterial activity of the bioactive com-
pounds detected in the chloroform fraction.
Furthermore, the differences in the antibacterial
spectrum of the methanol and the chloroform fraction
against the test bacteria might be linked to the differ-
ences in the composition and/or the concentration of
the secondary metabolites in the respective fractions.
For instance, unlike the chloroform fraction, the pres-
ence of alkaloids and saponins in methanol fraction
could directly or indirectly enhance its bacterial growth
inhibitory effects on gram negative bacteria including
E. coli and P. aeruginosa which were not responsive to
the chloroform fraction [34].
The zones of inhibition of the methanol fraction were
slightly higher than that of chloroform fraction against
each of susceptible strains for which both were active, at
equal concentrations. This may be associated with the
less diffusible components of the chloroform fraction on
the aqueous surfaces of the agar plate [35, 36] and their
differences in the composition and concentrations of
bioactive secondary metabolites.
Unlike the methanol and chloroform fractions, the
aqueous fraction was found to be devoid of antibacterial
activities against all the test bacterial strains regardless of
the concentrations tested. Such type of result in the
Table 6 Preliminary phytochemical investigation of the crude
extract and the solvent fractions of leaves of Rhamnus prinoides










Alkaloids + - + -
Saponins + - + +
Tannins + + + -
Anthraquinones + + - -
Polyphenols + + + -
Terpenoids + + + -
Flavonoids + + + -
Cardiac glycosides - - - -
+ = present, - = absent
Table 5 The MBC (in mg/ml) of the crude extract and the solvent fractions of Rhamnus prinoides against gram positive and gram
negative bacteria
Bacteria Crude extract Solvent fractions
Methanol fraction Chloroform fraction
MBC MBC MBC
S. aureus Stand. 2.03 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
Clinc. 4.06 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
S. pyogen Stand. 4.06 ± 0.00 13.54 ± 2.71 16.25 ± 0.00
Clinc. 4.06 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
S. pneumoniae Stand. 8.13 ± 0.00 32.50 ± 0.00 32.50 ± 0.00
Clinc. 16.25 ± 0.00 32.50 ± 0.00 32.50 ± 0.00
S. flexneri Stand. 8.13 ± 0.00 32.50 ± 0.00 16.25 ± 0.00
Clinc. 8.13 ± 0.00 32.50 ± 0.00 32.50 ± 0.00
E. coli Stand. 8.13 ± 0.00 32.50 ± 0.00 —
Clinc. 8.13 ± 0.00 65.00 ± 0.00 —
P. aeruginosa Stand. 8.13 ± 0.00 32.50 ± 0.00 —
Clinic. 8.13 ± 0.00 32.50 ± 0.00 —
S. typhi Stand 4.06 ± 0.00 16.25 ± 0.00 16.25 ± 0.00
MBC =Minimum Bactericidal Concentration, the values are the average of triplicate tests. Stand. = standard (ATCC) strains whereas Clinic. = clinically isolated strains
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present study is concordant with other similar study fol-
lowing the same solvent fractionation principles in which
the aqueous fraction was not having antibacterial activities
[37]. The plausible reason for this phenomenon might be
due to the localization of the secondary metabolites of the
plant in the chloroform and methanol fractions as the
plant had been extracted in sequential solvents of increas-
ing polarity. The localization of bioactive metabolites in
the active fractions can be supported by the fact that most
of the secondary metabolites of the medicinal plants have
aromatic rings and hence could be extracted by the or-
ganic solvents used sufficiently before being extracted by
water [38], which can further be strengthened by the
absence of almost all of the secondary metabolites tested
in aqueous fraction.
The antibacterial screening findings in terms of zone
of inhibition of the crude and the active solvent fractions
of Rhamnus prinoides against the respective susceptible
bacteria were inversely proportional to their values of
MIC and MBC, with some exception like for S. pneumo-
niae, that is, the more susceptible the bacteria to the
crude extract or the solvent fraction, the less is its corre-
sponding MIC and MBC values, suggesting the reprodu-
cibility and consistency of the experiments. In addition,
in almost all findings, the MBC value was equals to or
one dilution factor greater than that of the MIC value
for each bacterium in the microbroth dilution tests of
crude extract and the active solvent fractions, which
might indicate the sensitivity of the dilution method in
detecting the minimum bacterial turbidity that indicated
the growth of bacteria than that of the visual inspection
method in which ambiguity of determining the MIC
value is common [39].
However, the MIC values of clinical isolate of S. flexneri
for the crude extract and that of clinical isolate of S. aur-
eus and S. pyogen for the chloroform fraction were greater
than the corresponding values of the standard strains of
the same species. In addition, the MBC values of clinical
isolates of S. aureus and S. pneumoniae for crude extract;
S. pyogen and E. coli for methanol fraction; and S. flexneri
for chloroform were greater than the corresponding values
of the standard strains of the same species. These differ-
ences in the potency of the crude extract and the active
solvent fractions against the strains of the same bacterial
species might be associated to the susceptibility differ-
ences between the strains in which the clinical isolates
could have a higher chance of developing a resistance
mechanism of decreasing the access of the bioactive
metabolites to the target sites since they had been iso-
lated from the clinic settings in which resistant strains
are common [40].
Groups of phytochemical compounds commonly asso-
ciated antimicrobial activity in medicinal plants are fla-
vonoids, alkaloids, tannins, triterpenoids, essential oils,
saponins, glycosides and phenols [41, 42]. Therefore, the
antibacterial activity of the leaves of Rhamnus prinoides
might be attributed to either the individual class of these
compounds present in the crude and the active solvent
fractions or to the synergistic effect that each class of
compound exerted to give the observed antibacterial ac-
tivity findings.
Conclusion
The present study revealed that the chloroform fraction
and the methanol fraction of the leaves of Rhamnus pri-
noides have antibacterial activities against the growth of
the selected pathogenic bacteria with varying antibacter-
ial spectrum. Therefore, this study provides scientific
support for the traditional use of the medicinal plant in
the treatment of bacterial infections that are probably
caused by the susceptible bacteria. Further studies aimed
at the isolation and identification of active substance in
the crude extract, methanol and chloroform fractions of
the leaves of Rhamnus prinoides could disclose com-
pounds with better therapeutic values.
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